Rezolute, Inc.
RZLTNasdaqCIK 1509261HealthcareFiscal year ends Jun 30
Reports and events: 296 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2116:47 ET | DEF 14A | Proxy statementPeriod 2026-12-02 | 0001104659-26-117868 |
| 2026-10-1417:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115874 |
| 2026-10-0508:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-113503 |
| 2026-09-2416:24 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001104659-26-110420 |
| 2026-09-2416:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-110412 |
| 2026-06-0207:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-069206 |
| 2026-05-1216:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059422 |
| 2026-05-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059392 |
| 2026-05-0416:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-054943 |
| 2026-03-2407:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-033592 |
| 2026-02-1216:36 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001104659-26-014334 |
| 2026-02-1216:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-014287 |
| 2026-01-0706:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001556 |
| 2025-11-2116:59 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-115050 |
| 2025-11-1206:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-109559 |
| 2025-11-0616:29 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107781 |
| 2025-11-0616:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107743 |
| 2025-10-2116:56 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors | 0001104659-25-101282 |
| 2025-10-0716:16 ET | DEF 14A | Proxy statementPeriod 2025-11-19 | 0001104659-25-097509 |
| 2025-09-1716:24 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001104659-25-090848 |
| 2025-09-1716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-090834 |
| 2025-09-0206:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-085892 |
| 2025-08-2006:06 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-080473 |
| 2025-07-1806:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-068804 |
| 2025-06-1316:04 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001104659-25-059340 |
| 2025-06-1316:02 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-059336 |
| 2025-05-1316:25 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007582 |
| 2025-05-1316:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-047832 |
| 2025-04-2817:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-040271 |
| 2025-04-2317:22 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-038096 |
| 2025-04-2308:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-037746 |
| 2025-03-2816:52 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-029429 |
| 2025-02-1216:28 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001558370-25-000867 |
| 2025-02-1216:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-012173 |
| 2025-02-0417:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-009180 |
| 2025-01-1416:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-003460 |
| 2025-01-0716:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-001666 |
| 2024-12-1016:43 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-127228 |
| 2024-11-0716:47 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014893 |
| 2024-11-0716:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115351 |
| 2024-10-2116:41 ET | DEF 14A | Proxy statementPeriod 2024-12-05 | 0001104659-24-110244 |
| 2024-09-1916:23 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001558370-24-012901 |
| 2024-09-1916:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-101342 |
| 2024-09-0907:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-097969 |
| 2024-08-0507:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-085614 |
| 2024-06-2817:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-076382 |
| 2024-06-2708:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-075387 |
| 2024-06-1416:51 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-071813 |
| 2024-05-2414:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-065073 |
| 2024-05-1716:21 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-063029 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.